Kennedy R. Lees
University of Glasgow
467 Papers
3.9K Citations
Kennedy R. Lees is an academic researcher from University of Glasgow. The author has contributed to research in topics: Stroke & Medicine. The author has an hindex of 86, co-authored 455 publications. Previous affiliations of Kennedy R. Lees include Ludwig Maximilian University of Munich & Cedars-Sinai Medical Center.
Chat about Author
Papers
Impact and influences on caregiver outcomes at one year post-stroke.
TL;DR: In this article, four outcome measures of carer stress and coping at one year post-stroke were identified: carer general health, anxiety, depression, and perception of stress.
A multicenter, randomized, double‐blinded, placebo‐controlled phase III study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III)
Wendy C. Ziai,Stanley Tuhrim,Karen Lane,Nichol McBee,Kennedy R. Lees,Jesse Dawson,Kenneth Butcher,Paul M. Vespa,David W. Wright,Penelope M. Keyl,A. David Mendelow,Carlos S. Kase,Christine A.C. Wijman,Marc Lapointe,Sayona John,Richard E. Thompson,Carol B. Thompson,Steven Mayo,Pat Reilly,Scott Janis,Issam A. Awad,Daniel F. Hanley +21 more
TL;DR: It is hypothesized that patients with small parenchymal haematoma volumes and relatively large IVH causing acute obstructive hydrocephalus would have improved clinical outcomes when given injections of low-dose rtPA to accelerate lysis and evacuation of IVH compared with placebo.
Improving economic evaluations in stroke: A report from the ESO Health Economics Working Group:
Dominique A Cadilhac,Dominique A Cadilhac,Joosup Kim,Joosup Kim,Alastair Wilson,Eivind Berge,Anita Patel,Myzoon Ali,Myzoon Ali,Jeffrey L. Saver,Hanne Christensen,Matthieu Cuche,Sean Crews,Olivia Wu,Marine Provoyeur,Peter McMeekin,Isabelle Durand-Zaleski,Gary A. Ford,Natalia Muhlemann,Philip M.W. Bath,Azmil H. Abdul-Rahim,Katharina S. Sunnerhagen,Atte Meretoja,Atte Meretoja,Vincent Thijs,Christian Weimar,Ayrton Roberto Massaro,Annemarei Ranta,Kennedy R. Lees +28 more
- 27 Jan 2020
TL;DR: A protocol template and guidance document for data collection will support a more standardised and transparent approach for economic evaluations of stroke care.
NXY-059 Brain or Vessel Protection
TL;DR: The publication this month of SAINT-I trial in the New England Journal of Medicine demonstrates a small but statistically significant improvement of the primary outcome by NXY-059 treatment, and reduced disability at 90 days as assessed by a shift in the modified Rankin scale.
A Simple, Assumption-Free, and Clinically Interpretable Approach for Analysis of Modified Rankin Outcomes
George Howard,Jennifer L. Waller,Jenifer H. Voeks,Virginia J. Howard,Edward C. Jauch,Kennedy R. Lees,Fenwick T. Nichols,Volker W. Rahlfs,David C. Hess +8 more
TL;DR: This work proposes to use tests to assess treatment differences addressing the metric, “if a patient is chosen at random from each treatment group and if they have different outcomes, what is the chance the patient who received the investigational treatment will have a better outcome than will the patient receiving the standard treatment?